Cvs Health (CVS) Long-Term Investments (2016 - 2026)

Cvs Health has reported Long-Term Investments for 11 years, with the latest figure at $32.4 billion in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments rose 2.93% year-over-year to $32.4 billion; the trailing twelve-month figure through Mar 2026 stood at $32.4 billion (up 2.93% YoY), and the FY2025 full-year result was $32.7 billion, up 4.24% from the prior year.
• Long-Term Investments for Q1 2026 stood at $32.4 billion, down from $32.7 billion in the prior quarter.
• The five-year high for Long-Term Investments was $32.7 billion in Q4 2025, with the low at $20.6 billion in Q3 2022.
• Historically, Long-Term Investments has averaged $27.0 billion across 5 years, with a median of $25.6 billion in 2022.
• Annual changes were most pronounced in 2023 — Long-Term Investments decreased 15.47% — and 2024, when it jumped 46.51%.
• Cvs Health's Long-Term Investments stood at $23.9 billion in 2022, then fell by 3.65% to $23.0 billion in 2023, then jumped by 36.15% to $31.3 billion in 2024, then increased by 4.24% to $32.7 billion in 2025, then fell by 0.8% to $32.4 billion in 2026.
• The last three Long-Term Investments figures came in at $32.4 billion (Q1 2026), $32.7 billion (Q4 2025), and $31.6 billion (Q3 2025), per Business Quant data.